Analysis of the implementation issues and countermeasures of medical-research-industry collaborative innovation policies based on the Smith-model
10.3760/cma.j.cn111325-20250613-00487
- VernacularTitle:基于史密斯模型的医研产协同创新政策执行问题与对策分析
- Author:
Danqing ZHOU
1
;
Bei XU
;
Rui ZHAO
;
Rui LIU
Author Information
1. 同济大学附属第十人民医院院长办公室，上海 200072
- Publication Type:Journal Article
- Keywords:
Policy implementation;
Medical-research-industry collaborative innovation;
Technological innovation platform;
Smith-model
- From:
Chinese Journal of Hospital Administration
2025;41(8):650-654
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the problems in implementing medical-research-industry collaborative innovation related policies, and propose corresponding countermeasures, for references for promoting the construction and development of collaborative innovation platforms in China.Methods:This study searched official websites such as the State Council, the National Health Commission and the Shanghai Municipal Health Commission for policy documents related to collaborative innovation and the transformation of medical scientific and technological achievements. Based on the Smith-model, 4 plaiforms of Shanghai were took, including the Clinical Science and Technology Innovation Park of Tongji University of Tenth People′s Hospital and other collaborative innovation platforms, as examples to analyze the problems in the implementation process of medical-research-industry collaborative innovation policies.Results:On the basis of national policies, Shanghai had issued a series of relevant guidance policies based on local conditions, creating a favorable policy environment for the construction and development of the medical-research-industry collaborative innovation platforms. However, the policy implications and practical needs related to collaborative innovation still needed to be continuously adjusted; The target demands of policy implementation entities were not unified, and there was a lack of normalized communication mechanisms; The target group lacked endogenous motivation and the policy implementation environment needed to be improved.Conclusions:The implementation of medical-research-industry collaborative innovation policies needed further improvement. It is suggested to optimize the policy supply coordination, performance evaluation and incentive mechanism, supervision and management, collaborative innovation culture atmosphere, and multi-channel funding support to promote the sustainable development of the collaborative innovation platform, and accelerate the efficient transformation of scientific and technological achievements.
